Project BioShield Should Exempt Device Firms From Liability – AdvaMed
This article was originally published in The Gray Sheet
Executive Summary
Liability protections under Project BioShield should be extended to companies that make countermeasure devices and diagnostics available in an emergency situation, AdvaMed says
You may also be interested in...
FDA Draft Guidance Proposes Emergency-Use Authorization Policies
Device and diagnostic firms should strive to contact FDA about emergency-use authorization for medical products before the agency officially declares an emergency, according to FDA draft guidelines
FDA Draft Guidance Proposes Emergency-Use Authorization Policies
Device and diagnostic firms should strive to contact FDA about emergency-use authorization for medical products before the agency officially declares an emergency, according to FDA draft guidelines
Project BioShield Mandatory Funding Meets Resistance In House
A White House plan to establish a permanent HHS funding stream to contract for bioweapon countermeasures ran into unexpected criticism from a bipartisan group of lawmakers March 27